Resonant Capital Advisors LLC Acquires 5,814 Shares of UnitedHealth Group Incorporated $UNH

Resonant Capital Advisors LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 162.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,392 shares of the healthcare conglomerate’s stock after purchasing an additional 5,814 shares during the quarter. Resonant Capital Advisors LLC’s holdings in UnitedHealth Group were worth $2,541,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Sarver Vrooman Wealth Advisors bought a new position in UnitedHealth Group during the 4th quarter worth $25,000. Beacon Financial Strategies CORP acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $26,000. Anfield Capital Management LLC raised its position in shares of UnitedHealth Group by 220.0% in the fourth quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate’s stock valued at $26,000 after buying an additional 55 shares in the last quarter. Joseph Group Capital Management acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $27,000. Finally, Nalls Sherbakoff Group LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $27,000. Institutional investors own 87.86% of the company’s stock.

More UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth said an external audit found nearly 97% of diagnoses in its HouseCalls home-health unit were supported by patient medical records, which may help ease concerns around lawmakers’ scrutiny of the business. Reuters article on home-health diagnoses audit
• Positive Sentiment: The company is emphasizing profitability over rapid growth, with improving margins, stronger earnings, and Optum expansion supporting a longer-term turnaround story. Yahoo Finance article on profitability over growth
• Positive Sentiment: UnitedHealth expanded coverage for Guardant Health’s Shield blood test for adults 45 and older, becoming the first major commercial insurer to do so and reinforcing its role in expanding access to new screening tools. Yahoo Finance article on Shield blood test coverage
• Positive Sentiment: HSBC raised its price target on UNH to $380 and maintained a hold rating, signaling improved sentiment even though the new target remains below the current trading range. Benzinga report on HSBC target increase
• Neutral Sentiment: Several market commentaries highlighted UNH’s rebound, momentum profile, and long-term earnings recovery potential, but these pieces were mostly opinion-driven rather than fresh company-specific catalysts. MSN article on long-term momentum
• Neutral Sentiment: Articles comparing UnitedHealth with peers or discussing recent stock weakness provide context, but they do not add a major new fundamental catalyst on their own. Yahoo Finance article on recent stock decline

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 800 shares of the firm’s stock in a transaction dated Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the transaction, the chief executive officer directly owned 17,805 shares in the company, valued at $6,320,775. This trade represents a 4.30% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.28% of the company’s stock.

UnitedHealth Group Price Performance

UNH traded up $8.65 on Tuesday, reaching $426.64. The stock had a trading volume of 1,617,234 shares, compared to its average volume of 8,585,878. The firm has a 50-day moving average of $392.87 and a 200-day moving average of $335.60. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $430.20. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $387.45 billion, a price-to-earnings ratio of 32.21, a price-to-earnings-growth ratio of 1.71 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The business had revenue of $111.65 billion during the quarter, compared to analyst estimates of $109.84 billion. During the same quarter last year, the business earned $7.20 EPS. The firm’s quarterly revenue was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 18.32 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were issued a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend was Monday, June 15th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.21. UnitedHealth Group’s dividend payout ratio (DPR) is presently 70.09%.

Analyst Ratings Changes

Several research firms recently weighed in on UNH. Jefferies Financial Group upped their price objective on shares of UnitedHealth Group from $340.00 to $373.00 and gave the stock a “buy” rating in a research report on Monday, April 20th. Wells Fargo & Company increased their price target on shares of UnitedHealth Group from $370.00 to $397.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 22nd. HC Wainwright set a $492.00 target price on UnitedHealth Group in a research note on Wednesday, May 27th. Oppenheimer boosted their price target on UnitedHealth Group from $385.00 to $405.00 and gave the stock an “outperform” rating in a report on Wednesday, April 22nd. Finally, HSBC raised their price objective on UnitedHealth Group from $300.00 to $380.00 and gave the company a “hold” rating in a research note on Monday. One investment analyst has rated the stock with a Strong Buy rating, twenty-one have given a Buy rating, four have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $414.75.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.